Independent Monitoring Board
This page and its sub-pages are maintained by the Independent Monitoring Board and reflect the views of that body alone.
The Independent Monitoring Board (IMB) assesses progress towards the attainment of a polio-free world, providing independent monitoring and guidance on the work of Objective 1 of the GPEI Strategic Plan – the detection and interruption of poliovirus.
The IMB evaluates progress towards key milestones on the basis of polio epidemiology, poliovirus virology, standard performance indicators and other programme data. If milestones are found to be ‘at risk’, ‘off track’ or ‘missed’, the IMB advises countries, implementing partners, and/or donor agencies on the required corrective action plans, and evaluates the quality, implementation and impact of these plans.
The IMB is comprised of global experts from a variety of fields relevant to the work of the GPEI, and was established at the request of the Executive Board (EB) and the World Health Assembly (WHA). Reports from the Board’s meetings go directly to the heads of the spearheading partner agencies – the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC) and UNICEF – and the Bill & Melinda Gates Foundation and are public shortly afterwards.
The next IMB meeting will be held 31 October – 1 November 2017, in London, UK.